Kid Castle Educational Corporation (KDCE)
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Kid Castle Educational Corporation (KDCE) trades at $0.00 with AI Score 46/100 (Grade C). Kid Castle Educational Corporation (KDCE) is a diversified holding company managing interests across biopharmaceutical, agricultural, and specialized cannabidiol (CBD) markets in the United States. Market cap: $2,232, Sector: Industrials.
Price live · AI analysis from Jun 15, 2026Analyst Coverage for KDCE: KDCE does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates KDCE against Industrials peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
KDCE: the 1 perspectives are evenly split.
How is this calculated? →Kid Castle Educational Corporation (KDCE) Industrial Operations Profile
Kid Castle Educational Corporation (KDCE) operates as a diversified holding company, managing interests in biopharmaceutical, agricultural, and specialized cannabidiol (CBD) markets across the United States. Founded in 1986, the firm's CBD segment is particularly active in the procurement, processing, and distribution of various bulk CBD products, including isolates and THC-free distillates.
What Is the Investment Thesis for KDCE?
Kid Castle Educational Corporation (KDCE) presents an investment profile characterized by its unique diversification strategy and operational efficiency, despite its micro-cap status and OTC listing. The company actively manages holdings across biopharmaceutical, agricultural, and specialized CBD markets, offering exposure to distinct growth vectors. Its involvement in the bulk CBD market, encompassing procurement, processing, and distribution of products like pure CBD and THC-free distillates, positions it within a sector experiencing ongoing demand. Financially, KDCE exhibits remarkable profitability with a 74.8% profit margin and a 57.0% gross margin, suggesting highly efficient operations or strong pricing power within its niches. However, the company's 2K market capitalization and P/E of 0.00 indicate a non-reporting or extremely small entity, requiring deep due diligence. The reported Beta of -83.30 is an extreme outlier, suggesting an inverse and highly volatile relationship to the broader market, which warrants careful scrutiny. Key value drivers include potential for strategic expansion within its diversified portfolio and leveraging its high margins. Risks are significant, stemming from its OTC Other tier listing, which implies lower liquidity and less stringent reporting, alongside the operational implications of managing diverse holdings with only one employee. Investors must consider these factors in the context of its stated business activities.
Based on FMP financials and quantitative analysis
KDCE Key Highlights
- Market Capitalization: $0.00B, indicating a micro-cap or non-reporting entity.
- Profit Margin: 74.8%, demonstrating high profitability relative to revenue across its diverse holdings.
- Gross Margin: 57.0%, reflecting strong cost control and efficient operations in its core business segments.
- Employee Count: 1 employee, suggesting a highly lean or holding company structure for its portfolio management.
- Beta: -83.30, indicating an extremely inverse and highly unusual relationship to broader market movements, warranting further investigation.
Who Are KDCE's Competitors?
KDCE is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CRESY Cresud Sociedad Anónima, Comercial, Inmobiliaria, Financiera y Agropecuaria | $11.05 | +0.36% | $716.86M | 64 |
| RSDEF Ramsdens Holdings PLC | $2.39 | +0.00% | $78.15M | 59 |
| MPCFF Metro Pacific Investments Corporation | $0.05 | +0.00% | $1.43B | 58 |
| FIP FTAI Infrastructure Inc. | $4.43 | -0.23% | $523.46M | 57 |
| CODI Compass Diversified (CODI) | $10.26 | -3.30% | $771.92M | 48 |
| UMCN UMC, Inc. | $0.06 | -0.17% | $39.36M | 48 |
| KTERF Keio Corporation | $4.49 | +0.00% | $2.61B | 48 |
| AYYLF Ayala Corporation | $7.70 | +17.56% | $4.78B | 48 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are KDCE's Key Strengths?
- Diversified portfolio across biopharmaceutical, agricultural, and CBD markets, potentially mitigating single-sector risk.
- High profit margin of 74.8% and gross margin of 57.0%, indicating strong operational efficiency or market position.
- Established presence in the bulk CBD market, involved in procurement, processing, and distribution.
- Long operational history since 1986, suggesting foundational experience.
What Are KDCE's Weaknesses?
- Extremely lean operational structure with only one employee, potentially creating key-person dependency.
- Trading on the OTC Other tier, implying lower transparency and liquidity.
- Market capitalization of 2K and P/E of 0.00, indicating a non-reporting or extremely small entity.
- Anomalous Beta of -83.30, suggesting highly unusual and potentially unpredictable market behavior.
What Could Drive KDCE Stock Higher?
- Management of diverse holdings across biopharmaceutical, agricultural, and CBD markets, offering exposure to varied economic cycles.
- Procurement, processing, and distribution activities within the bulk CBD market, capitalizing on existing demand.
- Potential strategic initiatives to leverage high profit and gross margins for further growth or expansion into new market segments.
- Any future improvements in regulatory clarity or market acceptance for CBD products, potentially boosting demand and operational stability.
What Are the Key Risks for KDCE?
- Financial-distress signal — its Altman Z-Score of -2.77 sits in the distress zone (elevated bankruptcy risk).
- Operating on the OTC Other tier, which typically entails lower liquidity, less stringent reporting, and higher investment risk.
- Dependence on a single employee for managing a diverse portfolio, posing key-person risk and potential operational limitations.
- Regulatory changes or increased competition in the specialized cannabidiol (CBD) market could significantly impact operations and profitability.
- Market volatility, as indicated by an extremely negative Beta of -83.30, suggesting unusual and potentially unpredictable price movements.
- Challenges in accessing capital for growth or expansion due to its OTC listing and small market capitalization.
What Are the Growth Opportunities for KDCE?
- Expansion in the Bulk CBD Market: The global CBD market continues to expand, driven by increasing consumer awareness and diverse applications in health, wellness, and industrial products. KDCE's established involvement in the procurement, processing, and distribution of bulk CBD products, including isolates, hemp oil, and THC-free distillates, positions it to capitalize on this growth. As regulatory clarity improves and mainstream adoption increases, demand from manufacturers for high-quality, consistent bulk CBD is expected to rise. KDCE's current operational footprint and product range provide a foundation for scaling its supply chain and distribution networks to meet this escalating market need, potentially capturing a larger share of the B2B CBD segment.
- Leveraging Diversified Portfolio for Stability: KDCE's strategic management of holdings across biopharmaceutical, agricultural, and CBD markets offers inherent stability and potential for cross-sector synergies. This diversification can act as a buffer against volatility in any single market, allowing the company to reallocate resources or focus on segments experiencing stronger growth. For instance, advancements in agricultural technologies or specific biopharmaceutical breakthroughs could provide new revenue streams or enhance existing asset values, complementing its CBD operations. This multi-sector approach provides a broader base for sustained growth compared to single-industry focused entities, offering resilience in dynamic economic environments.
- Strategic Partnerships and Acquisitions: Given its lean operational structure with one employee, KDCE could pursue strategic partnerships or targeted acquisitions to expand its reach and capabilities without significantly increasing its internal overhead. Collaborations with established players in biopharmaceuticals or agriculture could provide access to new technologies, distribution channels, or intellectual property. Similarly, acquiring smaller, specialized CBD processors or distributors could rapidly enhance its market share and product offerings. This approach would allow KDCE to efficiently scale its operations and diversify its asset base, leveraging external expertise and infrastructure to drive growth across its varied holdings.
- Capitalizing on High Profitability for Reinvestment: KDCE's reported profit margin of 74.8% and gross margin of 57.0% are exceptionally strong, indicating highly efficient operations or a strong competitive position in its current markets. These robust margins generate significant internal capital that can be strategically reinvested into growth initiatives. This could include upgrading processing capabilities for CBD products, investing in research and development for its biopharmaceutical holdings, or expanding agricultural assets. The ability to self-fund growth through high profitability reduces reliance on external financing, providing greater flexibility and potentially accelerating expansion plans across its diverse portfolio segments.
- Untapped Niche Market Penetration: Within its broad biopharmaceutical and agricultural holdings, KDCE likely has opportunities to identify and penetrate highly specialized, underserved niche markets. These could involve specific agricultural commodities with high demand, unique biopharmaceutical compounds, or specialized processing services for the CBD industry. By focusing on these smaller, high-value segments, KDCE can avoid direct competition with larger industry players and establish strong market positions. This strategy aligns with a lean operational model, allowing for targeted investments and agile responses to emerging market demands, ultimately contributing to sustained revenue growth and profitability.
What Opportunities Does KDCE Have?
- Expansion within the growing global CBD market by leveraging existing procurement and processing capabilities.
- Strategic partnerships or targeted acquisitions to enhance capabilities and market reach across its diverse holdings.
- Reinvestment of high internal profitability into growth initiatives within biopharmaceutical, agricultural, or CBD segments.
- Identification and penetration of underserved niche markets within its broad sector focus.
What Threats Does KDCE Face?
- Increased regulatory scrutiny or adverse changes in legislation impacting the specialized CBD market.
- Intense competition from larger, more established players in the biopharmaceutical, agricultural, and CBD sectors.
- Risks associated with the OTC Other tier, including potential for market manipulation and difficulty in capital raising.
- Operational challenges or disruptions due to reliance on a single employee for managing diverse business interests.
What Are KDCE's Competitive Advantages?
- Diversified portfolio across distinct, potentially uncorrelated sectors (biopharma, agriculture, CBD) offering resilience.
- Established presence and operational involvement in the specialized bulk CBD market, including procurement and processing.
- Demonstrated high profit and gross margins, suggesting efficient operations, cost control, or strong pricing power within its niches.
What Does KDCE Do?
Kid Castle Educational Corporation (KDCE), headquartered in Torrance, California, operates as a diversified holding company with a strategic focus on managing a varied portfolio of interests across the United States. The company's operational scope encompasses the biopharmaceutical, agricultural, and specialized cannabidiol (CBD) markets. Founded in 1986, the firm initially operated under the name King Ball International Technology Corporation before officially adopting its current moniker, Kid Castle Educational Corporation, in August 2002. Despite its current name, the company's core business activities, as described, are centered on these diverse industrial sectors rather than educational programs. Within its specialized CBD operations, KDCE is actively involved in a comprehensive supply chain, ranging from the procurement of raw materials to the processing and distribution of a variety of bulk CBD products. This includes high-purity offerings such as pure CBD, isolates, and THC-free distillates, alongside more foundational products like hemp oil and crude CBD oil. These products serve various industrial and commercial clients within the burgeoning CBD market. The company's strategy appears to leverage diversification across distinct, yet potentially high-growth, sectors to manage risk and capture market opportunities. Its long operational history since 1986 suggests a foundational presence, though its current structure with a single employee indicates a highly lean or holding company model, potentially relying on external partnerships or a highly automated/outsourced operational framework for its diverse portfolio management and CBD supply chain activities. This unique operational setup allows KDCE to navigate complex market landscapes in biopharmaceuticals, agriculture, and the rapidly evolving CBD industry.
What Products and Services Does KDCE Offer?
- Manages a diverse portfolio of holdings across multiple sectors.
- Operates in the biopharmaceutical market within the United States.
- Engages in the agricultural market across the United States.
- Specializes in the cannabidiol (CBD) market, focusing on bulk products.
- Procures raw materials for its CBD product line.
- Processes various bulk CBD products, including pure CBD and isolates.
- Distributes specialized CBD products such as hemp oil and THC-free distillates.
- Sells crude CBD oil to industrial and commercial clients.
How Does KDCE Make Money?
- Generates revenue through the active management of a diversified portfolio spanning biopharmaceutical, agricultural, and CBD markets.
- Derives profits from the procurement, processing, and distribution of various bulk CBD products, serving B2B clients.
- Operates as a holding company, potentially managing investments and overseeing operational entities or outsourced functions across its diverse segments.
What Industry Does KDCE Operate In?
Kid Castle Educational Corporation operates within the Industrials sector, specifically categorized under Conglomerates, reflecting its diversified business model spanning biopharmaceutical, agricultural, and specialized cannabidiol (CBD) markets. This positioning allows KDCE to potentially mitigate risks associated with single-industry exposure by balancing different market cycles and demand drivers. The conglomerate structure, while offering diversification, also presents challenges in managing disparate operational complexities and market dynamics across its holdings. Within the competitive landscape, KDCE competes not only with other diversified holding companies but also with specialized firms in each of its operational segments. Its focus on bulk CBD products places it within a growing, yet highly regulated and competitive, segment of the wellness and industrial hemp market. The biopharmaceutical and agricultural sectors, while mature, offer specific niches for growth, particularly for lean operations capable of identifying and capitalizing on market inefficiencies or specialized product demands. KDCE's high profit and gross margins suggest it has found efficient operational models or strong market positions within its chosen segments, differentiating it from broader industry averages.
Who Are KDCE's Key Customers?
- Businesses and manufacturers requiring bulk CBD products for their own production and distribution.
- Entities within the biopharmaceutical industry that may utilize or partner with KDCE's holdings.
- Participants in the agricultural sector, depending on the specific nature of KDCE's agricultural holdings.
How Kid Castle Educational Corporation Is Valued
Kid Castle Educational Corporation carries a market capitalization of 2K, placing it in the micro-cap category. Relative to its peer group, KDCE's quantitative score of 46/100 is below the peer average of 57/100.
Company Profile
Kid Castle Educational Corporation operates in the Conglomerates industry within the Industrials sector. It is headquartered in Torrance, US. The company is led by CEO Frank Ikechukwu Igwealor. KDCE has traded publicly since 1998.
ROE 15%Key Financial Metrics
Return on equity for Kid Castle Educational Corporation stands at 15.3%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 13.0%, showing how much profit it generates from its asset base. KDCE trades at a trailing price-to-earnings ratio of 0.00, below the Industrials sector average of ~30x. A current ratio of 2.99 indicates the company holds enough short-term assets to cover its near-term obligations.
F-Score 4/9Financial Health
Kid Castle Educational Corporation's Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -2.77 places it in the distress zone, a signal of elevated financial risk.
KDCE Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in the company's growth potential, indicating a positive outlook from those closest to the business.
- Community sentiment has shifted positively, with increased discussions highlighting the company's innovative educational offerings.
- The market is recognizing the increasing demand for educational technology solutions, positioning KDCE favorably within this growing sector.
- Recent partnerships and collaborations have been announced, suggesting potential for expansion and increased market presence.
Bear Case
- Concerns about the overall economic environment may impact discretionary spending on educational products, leading to cautious sentiment.
- Bearish community views have emerged, with some analysts questioning the sustainability of recent growth trends in the education sector.
- Insider selling activity could raise red flags, suggesting that some executives may lack confidence in the company's future performance.
- Increased competition in the educational technology space may pose challenges for KDCE, impacting its market share and profitability.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
KDCE Latest News
No recent news available for KDCE.
KDCE Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for KDCE.
Price Targets
Wall Street price target analysis for KDCE.
KDCE MoonshotScore
What does this score mean?
The MoonshotScore rates KDCE's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Classification
Industry ConglomeratesLeadership: Frank Ikechukwu Igwealor
Chief Executive Officer
Frank Ikechukwu Igwealor serves as the Chief Executive Officer of Kid Castle Educational Corporation. Details regarding his specific educational background, prior career history, and tenure in other leadership roles are not provided in the available source data. He is noted for managing the company's operations, which encompass a diverse portfolio across biopharmaceutical, agricultural, and specialized cannabidiol (CBD) markets within the United States. His role involves overseeing the strategic direction and day-to-day management of the firm's varied holdings.
Track Record: Under Mr. Igwealor's leadership, Kid Castle Educational Corporation maintains a highly lean operational structure, evidenced by its single employee. The company has achieved notable financial metrics, including a 74.8% profit margin and a 57.0% gross margin, reflecting efficient management and strong profitability within its diverse portfolio of biopharmaceutical, agricultural, and CBD market interests. Specific strategic decisions or milestones beyond these financial outcomes are not detailed in the provided information.
KDCE OTC Market Information
The 'OTC Other' tier, where Kid Castle Educational Corporation (KDCE) trades, represents the lowest and most speculative segment of the OTC market. Unlike companies listed on major exchanges like NYSE or NASDAQ, which adhere to stringent listing standards regarding financial health, corporate governance, and minimum share prices, OTC Other companies have minimal or no public disclosure requirements. This tier is typically for companies that are not current in their reporting, are in financial distress, or have not provided any information to OTC Markets Group. Consequently, it offers significantly less transparency and regulatory oversight compared to higher OTC tiers like OTCQB or OTCQX, and certainly less than national exchanges.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Lack of transparent financial reporting and operational updates due to minimal disclosure requirements.
- Extremely low trading liquidity, making it difficult to buy or sell shares efficiently and at fair prices.
- Higher susceptibility to fraud and market manipulation due to less stringent regulatory oversight.
- Difficulty in obtaining reliable valuation metrics and comprehensive company information for due diligence.
- Limited access to capital markets for future growth or financing, hindering expansion opportunities.
- Verify the company's current financial statements, if any are publicly available, directly from the company or regulatory filings.
- Investigate any press releases or corporate announcements for recent operational updates or strategic shifts.
- Assess the actual business operations in biopharmaceuticals, agriculture, and CBD, independent of the company's name.
- Research the background and track record of the CEO, Frank Ikechukwu Igwealor, and the implications of the single-employee structure.
- Evaluate the market demand and competitive landscape for its specific CBD products and other holdings.
- Understand the current and potential future regulatory environment for CBD and its impact on KDCE's operations.
- Consider the extreme Beta value of -83.30 and its implications for portfolio volatility and risk assessment.
- Existence of a physical corporate headquarters located in Torrance, California.
- A long operational history, with the company founded in 1986.
- Explicit description of diverse business operations in biopharmaceutical, agricultural, and CBD markets in its official business description.
- Reported high profit and gross margins, suggesting actual business activity and financial performance.
What Investors Ask About Kid Castle Educational Corporation (KDCE) — Industrials
What is Kid Castle Educational Corporation's primary business focus?
Kid Castle Educational Corporation (KDCE) primarily operates as a diversified holding company, managing a portfolio of interests across three distinct sectors: biopharmaceuticals, agriculture, and specialized cannabidiol (CBD) markets within the United States. Despite its name, the company's core business activities are centered on these industrial segments. Within its CBD operations, KDCE is actively involved in the entire supply chain, from the procurement to the processing and distribution of various bulk CBD products. This includes high-purity items such as pure CBD, isolates, and THC-free distillates, as well as hemp oil and crude CBD oil, serving B2B clients in the growing CBD industry.
How does KDCE's OTC listing impact investors?
Kid Castle Educational Corporation's listing on the OTC Other tier significantly impacts investors due to its inherent characteristics. This tier is associated with minimal public disclosure requirements, meaning investors may have limited access to timely and comprehensive financial or operational information, making informed decisions challenging. Furthermore, stocks on the OTC Other tier typically suffer from extremely low liquidity, resulting in wide bid-ask spreads and difficulty in executing trades efficiently. This can lead to increased price volatility and a higher risk of manipulation, as regulatory oversight is substantially less stringent compared to major exchanges like the NYSE or NASDAQ.
What are the key financial metrics investors may want to evaluate for KDCE?
For Kid Castle Educational Corporation, investors should closely examine several key financial metrics. The reported profit margin of 74.8% and gross margin of 57.0% are exceptionally high, indicating strong operational efficiency or significant pricing power within its niche markets, which warrants further investigation into its revenue streams and cost structure. The 2K market capitalization and P/E ratio of 0.00 suggest it is either a non-reporting entity or extremely small, requiring a deep dive into any available financial statements. Crucially, the Beta of -83.30 is an extreme outlier, implying an inverse and highly volatile relationship to the broader market, which is highly unusual and demands thorough understanding of its drivers.
How does Kid Castle Educational Corporation manage its diverse portfolio with only one employee?
Kid Castle Educational Corporation's management of a diverse portfolio across biopharmaceutical, agricultural, and CBD markets with only one reported employee, Frank Ikechukwu Igwealor, suggests a highly specialized and lean operational model. This structure likely indicates that the company functions primarily as a holding entity, overseeing investments and potentially outsourcing significant operational functions such as processing, distribution, or even research and development to third-party contractors or partners. This approach allows KDCE to maintain a minimal internal overhead while still participating in multiple complex industries. Investors may want to evaluate that this model places substantial reliance on the single employee for strategic oversight and management of external relationships, which could present both efficiency benefits and concentration risks.
What are the key factors to evaluate for KDCE?
Kid Castle Educational Corporation (KDCE) holds an AI score of 46/100 (low). Not financial advice.
How frequently does KDCE data refresh on this page?
KDCE prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven KDCE's recent stock price performance?
Kid Castle Educational Corporation (KDCE) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Diversified portfolio across biopharmaceutical, agricultural, and CBD markets, potentially mitigating single-sector risk. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider KDCE overvalued or undervalued right now?
Valuing Kid Castle Educational Corporation (KDCE) requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- The AI Insight provided a conflicting description of the company's core business, stating a focus on education, while the primary Business Description explicitly details operations in biopharmaceutical, agricultural, and CBD markets. The dossier prioritizes the explicit Business Description.
- Details regarding the CEO's background, track record, and tenure are limited in the provided source data.
- Competitor information was not provided in the source data.
- The extremely negative Beta value (-83.30) is highly unusual and warrants additional independent verification and analysis.